ESR1 and cancer: Previously, it has been shown that fulvestrant down-regulates the activity of ER-α and has excellent anti-proliferative efficacy in several cancers dealing with ER+ breast [88], ovarian [89], non-small cell lung [90] and gastric cancer cells [91].